It's no secret that developing a new drug or medical device is an expensive and time-consuming endeavor. Often, despite the best efforts of those involved, traditional clinical trials end up wasting ...
NORTHAMPTON, MA / ACCESS Newswire / February 11, 2026 / The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards), along with the American Heart Association (Heart Association), and ...
NATIONAL — [March 31, 2026] — The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards), an initiative dedicated to improving participation in and access to clinical trials, is ...
STATEN ISLAND, N.Y., March 9, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for ...
Qualcomm Life announced two major partnerships at CES15 this year: one with pharmaceutical company Novartis and the other with pharmacy chain Walgreens. Novartis selected Qualcomm Life as a partner ...
Clinical trials are frightening endeavors for biotech investors. Expensive and fraught with risk, a trial’s failure can seriously lighten an investor’s pockets with little hope of recourse. After ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results